Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis
ABSTRACT Treatment options for multiple sclerosis (MS) have changed over the last few years, bringing about a new category of drugs with more efficient profiles. However, these drugs have come with a whole new profile of potential adverse events that neurologists have to learn well and quickly. One of the most feared complications of these MS treatments is progressive multifocal leukoencephalopathy caused by the reactivation of the John Cunningham virus (JCV). Objective: To identify the serologic profile of JCV in patients with MS. Methods: Data on serum antibodies for JCV were obtained using the enzyme-linked immunosorbent assay provided by the STRATIFY-JCV program. Results: A total of 1,501 blood tests were obtained from 1,102 patients with MS. There were 633 patients (57.1%) who were positive for antibodies for JCV and 469 patients who were negative (42.9%). Twenty-three patients became positive after initially having negative JCV antibody status. The rate of seroconversion was 18.5% over 22 months. Conclusion: The JCV serologic profile and seroconversion in Brazilian patients were similar to those described in other countries.
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Academia Brasileira de Neurologia - ABNEURO
2018
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000900588 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0004-282X2018000900588 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0004-282X20180009005882018-10-10Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosisBranco,Luciana PratsAdoni,TarsoApostolos-Pereira,Samira LuisaBrooks,Joseph Bruno BidinCorrea,Eber CastroDamasceno,Carlos AugustoEboni,Audred Cristina BiondoFezer,LeticiaGama,Paulo Diniz daGoncalves,Marcus Vinicius MagnoGomes,SidneyGrzesiuk,Anderson KuntzMendes,Maria FernandaMorales,Rogerio RizoMuniz,AndreParolin,Monica Fiuza KonckePimentel,Maria Lucia VellutiniRibeiro,Marlise de CastroSantos,Gutemberg Augusto Cruz dosSato,Henry KoitiScherpenhuijzen,Simone BatistaScorcine,ClaudioSiquineli,FabioSousa,Nise Alexandra de CarvalhoVarela,Daniel LimaWinckler,Tereza Cristina AvilaFragoso,Yara Dadalti multiple sclerosis leukoencephalopathy, progressive multifocal JC virus natalizumab ABSTRACT Treatment options for multiple sclerosis (MS) have changed over the last few years, bringing about a new category of drugs with more efficient profiles. However, these drugs have come with a whole new profile of potential adverse events that neurologists have to learn well and quickly. One of the most feared complications of these MS treatments is progressive multifocal leukoencephalopathy caused by the reactivation of the John Cunningham virus (JCV). Objective: To identify the serologic profile of JCV in patients with MS. Methods: Data on serum antibodies for JCV were obtained using the enzyme-linked immunosorbent assay provided by the STRATIFY-JCV program. Results: A total of 1,501 blood tests were obtained from 1,102 patients with MS. There were 633 patients (57.1%) who were positive for antibodies for JCV and 469 patients who were negative (42.9%). Twenty-three patients became positive after initially having negative JCV antibody status. The rate of seroconversion was 18.5% over 22 months. Conclusion: The JCV serologic profile and seroconversion in Brazilian patients were similar to those described in other countries.info:eu-repo/semantics/openAccessAcademia Brasileira de Neurologia - ABNEUROArquivos de Neuro-Psiquiatria v.76 n.9 20182018-09-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000900588en10.1590/0004-282x20180083 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Branco,Luciana Prats Adoni,Tarso Apostolos-Pereira,Samira Luisa Brooks,Joseph Bruno Bidin Correa,Eber Castro Damasceno,Carlos Augusto Eboni,Audred Cristina Biondo Fezer,Leticia Gama,Paulo Diniz da Goncalves,Marcus Vinicius Magno Gomes,Sidney Grzesiuk,Anderson Kuntz Mendes,Maria Fernanda Morales,Rogerio Rizo Muniz,Andre Parolin,Monica Fiuza Koncke Pimentel,Maria Lucia Vellutini Ribeiro,Marlise de Castro Santos,Gutemberg Augusto Cruz dos Sato,Henry Koiti Scherpenhuijzen,Simone Batista Scorcine,Claudio Siquineli,Fabio Sousa,Nise Alexandra de Carvalho Varela,Daniel Lima Winckler,Tereza Cristina Avila Fragoso,Yara Dadalti |
spellingShingle |
Branco,Luciana Prats Adoni,Tarso Apostolos-Pereira,Samira Luisa Brooks,Joseph Bruno Bidin Correa,Eber Castro Damasceno,Carlos Augusto Eboni,Audred Cristina Biondo Fezer,Leticia Gama,Paulo Diniz da Goncalves,Marcus Vinicius Magno Gomes,Sidney Grzesiuk,Anderson Kuntz Mendes,Maria Fernanda Morales,Rogerio Rizo Muniz,Andre Parolin,Monica Fiuza Koncke Pimentel,Maria Lucia Vellutini Ribeiro,Marlise de Castro Santos,Gutemberg Augusto Cruz dos Sato,Henry Koiti Scherpenhuijzen,Simone Batista Scorcine,Claudio Siquineli,Fabio Sousa,Nise Alexandra de Carvalho Varela,Daniel Lima Winckler,Tereza Cristina Avila Fragoso,Yara Dadalti Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis |
author_facet |
Branco,Luciana Prats Adoni,Tarso Apostolos-Pereira,Samira Luisa Brooks,Joseph Bruno Bidin Correa,Eber Castro Damasceno,Carlos Augusto Eboni,Audred Cristina Biondo Fezer,Leticia Gama,Paulo Diniz da Goncalves,Marcus Vinicius Magno Gomes,Sidney Grzesiuk,Anderson Kuntz Mendes,Maria Fernanda Morales,Rogerio Rizo Muniz,Andre Parolin,Monica Fiuza Koncke Pimentel,Maria Lucia Vellutini Ribeiro,Marlise de Castro Santos,Gutemberg Augusto Cruz dos Sato,Henry Koiti Scherpenhuijzen,Simone Batista Scorcine,Claudio Siquineli,Fabio Sousa,Nise Alexandra de Carvalho Varela,Daniel Lima Winckler,Tereza Cristina Avila Fragoso,Yara Dadalti |
author_sort |
Branco,Luciana Prats |
title |
Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis |
title_short |
Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis |
title_full |
Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis |
title_fullStr |
Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis |
title_full_unstemmed |
Serological profile of John Cunningham virus (JCV) in patients with multiple sclerosis |
title_sort |
serological profile of john cunningham virus (jcv) in patients with multiple sclerosis |
description |
ABSTRACT Treatment options for multiple sclerosis (MS) have changed over the last few years, bringing about a new category of drugs with more efficient profiles. However, these drugs have come with a whole new profile of potential adverse events that neurologists have to learn well and quickly. One of the most feared complications of these MS treatments is progressive multifocal leukoencephalopathy caused by the reactivation of the John Cunningham virus (JCV). Objective: To identify the serologic profile of JCV in patients with MS. Methods: Data on serum antibodies for JCV were obtained using the enzyme-linked immunosorbent assay provided by the STRATIFY-JCV program. Results: A total of 1,501 blood tests were obtained from 1,102 patients with MS. There were 633 patients (57.1%) who were positive for antibodies for JCV and 469 patients who were negative (42.9%). Twenty-three patients became positive after initially having negative JCV antibody status. The rate of seroconversion was 18.5% over 22 months. Conclusion: The JCV serologic profile and seroconversion in Brazilian patients were similar to those described in other countries. |
publisher |
Academia Brasileira de Neurologia - ABNEURO |
publishDate |
2018 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000900588 |
work_keys_str_mv |
AT brancolucianaprats serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT adonitarso serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT apostolospereirasamiraluisa serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT brooksjosephbrunobidin serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT correaebercastro serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT damascenocarlosaugusto serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT eboniaudredcristinabiondo serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT fezerleticia serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT gamapaulodinizda serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT goncalvesmarcusviniciusmagno serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT gomessidney serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT grzesiukandersonkuntz serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT mendesmariafernanda serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT moralesrogeriorizo serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT munizandre serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT parolinmonicafiuzakoncke serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT pimentelmarialuciavellutini serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT ribeiromarlisedecastro serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT santosgutembergaugustocruzdos serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT satohenrykoiti serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT scherpenhuijzensimonebatista serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT scorcineclaudio serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT siquinelifabio serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT sousanisealexandradecarvalho serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT vareladaniellima serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT wincklerterezacristinaavila serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis AT fragosoyaradadalti serologicalprofileofjohncunninghamvirusjcvinpatientswithmultiplesclerosis |
_version_ |
1756374755399696384 |